189 related articles for article (PubMed ID: 10866371)
21. Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
Mimoto T; Kato R; Takaku H; Nojima S; Terashima K; Misawa S; Fukazawa T; Ueno T; Sato H; Shintani M; Kiso Y; Hayashi H
J Med Chem; 1999 May; 42(10):1789-802. PubMed ID: 10346931
[TBL] [Abstract][Full Text] [Related]
22. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors.
Baker CT; Salituro FG; Court JJ; Deininger DD; Kim EE; Li B; Novak PM; Rao BG; Pazhanisamy S; Schairer WC; Tung RD
Bioorg Med Chem Lett; 1998 Dec; 8(24):3631-6. PubMed ID: 9934484
[TBL] [Abstract][Full Text] [Related]
24. Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicity.
Chen P; Cheng PT; Alam M; Beyer BD; Bisacchi GS; Dejneka T; Evans AJ; Greytok JA; Hermsmeier MA; Humphreys WG; Jacobs GA; Kocy O; Lin PF; Lis KA; Marella MA; Ryono DE; Sheaffer AK; Spergel SH; Sun CQ; Tino JA; Vite G; Colonno RJ; Zahler R; Barrish JC
J Med Chem; 1996 May; 39(10):1991-2007. PubMed ID: 8642558
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.
Sherrill RG; Furfine ES; Hazen RJ; Miller JF; Reynolds DJ; Sammond DM; Spaltenstein A; Wheelan P; Wright LL
Bioorg Med Chem Lett; 2005 Aug; 15(15):3560-4. PubMed ID: 15975788
[TBL] [Abstract][Full Text] [Related]
26. P1' oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1.
Kim RM; Rouse EA; Chapman KT; Schleif WA; Olsen DB; Stahlhut M; Rutkowski CA; Emini EA; Tata JR
Bioorg Med Chem Lett; 2004 Sep; 14(18):4651-4. PubMed ID: 15324882
[TBL] [Abstract][Full Text] [Related]
27. New, potent P1/P2-morpholinone-based HIV-protease inhibitors.
Kazmierski WM; Furfine E; Spaltenstein A; Wright LL
Bioorg Med Chem Lett; 2006 Oct; 16(19):5226-30. PubMed ID: 16904316
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors.
Smith AB; Cantin LD; Pasternak A; Guise-Zawacki L; Yao W; Charnley AK; Barbosa J; Sprengeler PA; Hirschmann R; Munshi S; Olsen DB; Schleif WA; Kuo LC
J Med Chem; 2003 May; 46(10):1831-44. PubMed ID: 12723947
[TBL] [Abstract][Full Text] [Related]
29. Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties.
Kazmierski WM; Andrews W; Furfine E; Spaltenstein A; Wright L
Bioorg Med Chem Lett; 2004 Nov; 14(22):5689-92. PubMed ID: 15482949
[TBL] [Abstract][Full Text] [Related]
30. Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
Böttcher J; Blum A; Dörr S; Heine A; Diederich WE; Klebe G
ChemMedChem; 2008 Sep; 3(9):1337-44. PubMed ID: 18720485
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiviral activity of P1' arylsulfonamide azacyclic urea HIV protease inhibitors.
Huang PP; Randolph JT; Klein LL; Vasavanonda S; Dekhtyar T; Stoll VS; Kempf DJ
Bioorg Med Chem Lett; 2004 Aug; 14(15):4075-8. PubMed ID: 15225729
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors.
Randolph JT; Huang PP; Flosi WJ; DeGoey D; Klein LL; Yeung CM; Flentge C; Sun M; Zhao C; Dekhtyar T; Mo H; Colletti L; Kati W; Marsh KC; Molla A; Kempf DJ
Bioorg Med Chem; 2006 Jun; 14(12):4035-46. PubMed ID: 16504523
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands.
Qiu X; Zhao GD; Tang LQ; Liu ZP
Bioorg Med Chem Lett; 2014 Jun; 24(11):2465-8. PubMed ID: 24767846
[TBL] [Abstract][Full Text] [Related]
34. Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.
Miller JF; Andrews CW; Brieger M; Furfine ES; Hale MR; Hanlon MH; Hazen RJ; Kaldor I; McLean EW; Reynolds D; Sammond DM; Spaltenstein A; Tung R; Turner EM; Xu RX; Sherrill RG
Bioorg Med Chem Lett; 2006 Apr; 16(7):1788-94. PubMed ID: 16458505
[TBL] [Abstract][Full Text] [Related]
35. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
Nakatani S; Hidaka K; Ami E; Nakahara K; Sato A; Nguyen JT; Hamada Y; Hori Y; Ohnishi N; Nagai A; Kimura T; Hayashi Y; Kiso Y
J Med Chem; 2008 May; 51(10):2992-3004. PubMed ID: 18426195
[TBL] [Abstract][Full Text] [Related]
36. Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746.
Franchetti P; Perlini P; Abu Sheikha G; Cappellacci L; Grifantini M; Loi AG; De Montis A; Pani A; Marongiu ME; La Colla P
Antivir Chem Chemother; 1998 Jul; 9(4):303-9. PubMed ID: 9875409
[TBL] [Abstract][Full Text] [Related]
37. Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality.
Lu D; Vince R
Bioorg Med Chem Lett; 2007 Oct; 17(20):5614-9. PubMed ID: 17822899
[TBL] [Abstract][Full Text] [Related]
38. Stereoisomers of cyclic urea HIV-1 protease inhibitors: synthesis and binding affinities.
Kaltenbach RF; Nugiel DA; Lam PY; Klabe RM; Seitz SP
J Med Chem; 1998 Dec; 41(25):5113-7. PubMed ID: 9836627
[TBL] [Abstract][Full Text] [Related]
39. Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas.
Lam PY; Ru Y; Jadhav PK; Aldrich PE; DeLucca GV; Eyermann CJ; Chang CH; Emmett G; Holler ER; Daneker WF; Li L; Confalone PN; McHugh RJ; Han Q; Li R; Markwalder JA; Seitz SP; Sharpe TR; Bacheler LT; Rayner MM; Klabe RM; Shum L; Winslow DL; Kornhauser DM; Hodge CN
J Med Chem; 1996 Aug; 39(18):3514-25. PubMed ID: 8784449
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel HIV-1 protease inhibitors with pentacyclic triterpenoids as P2-ligands.
Zhu M; Du XN; Li YG; Zhang GN; Wang JX; Wang YC
Bioorg Med Chem Lett; 2019 Feb; 29(3):357-361. PubMed ID: 30580917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
